.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
US Army
Cerilliant
Queensland Health
Moodys
Daiichi Sankyo
Fuji
Colorcon
US Department of Justice

Generated: December 18, 2017

DrugPatentWatch Database Preview

GLYBURIDE (MICRONIZED) Drug Profile

« Back to Dashboard

Which patents cover Glyburide (micronized), and when can generic versions of Glyburide (micronized) launch?

Glyburide (micronized) is a drug marketed by Dava Pharms Inc, Hikma, Mylan, Sandoz, Sanofi Aventis Us, and Teva. and is included in six NDAs.

The generic ingredient in GLYBURIDE (MICRONIZED) is glyburide. There are twenty drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the glyburide profile page.
Drug patent expirations by year for GLYBURIDE (MICRONIZED)

Pharmacology for GLYBURIDE (MICRONIZED)

Ingredient-typeSulfonylurea Compounds
Drug ClassSulfonylurea

Medical Subject Heading (MeSH) Categories for GLYBURIDE (MICRONIZED)

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dava Pharms IncGLYBURIDE (MICRONIZED)glyburideTABLET;ORAL074591-001Dec 22, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
TevaGLYBURIDE (MICRONIZED)glyburideTABLET;ORAL074686-003Apr 20, 1999ABRXNoNo► Subscribe► Subscribe► Subscribe
HikmaGLYBURIDE (MICRONIZED)glyburideTABLET;ORAL075890-003Jul 31, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe
Dava Pharms IncGLYBURIDE (MICRONIZED)glyburideTABLET;ORAL074591-004Dec 22, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
SandozGLYBURIDE (MICRONIZED)glyburideTABLET;ORAL075174-002Jun 22, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
MylanGLYBURIDE (MICRONIZED)glyburideTABLET;ORAL074792-001Jun 26, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe
TevaGLYBURIDE (MICRONIZED)glyburideTABLET;ORAL074686-004Apr 20, 1999ABRXNoNo► Subscribe► Subscribe► Subscribe
TevaGLYBURIDE (MICRONIZED)glyburideTABLET;ORAL074686-001Apr 20, 1999ABRXNoNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis UsGLYBURIDE (MICRONIZED)glyburideTABLET;ORAL020055-002Apr 17, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Dava Pharms IncGLYBURIDE (MICRONIZED)glyburideTABLET;ORAL074591-002Dec 22, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cantor Fitzgerald
US Army
Julphar
Fuji
Accenture
Fish and Richardson
Novartis
Deloitte
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot